NCT06387966View on ClinicalTrials.gov

A Phase I Clinical Study of Flonoltinib Maleate Tablets in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

March 18, 2024

Primary Completion Date

August 15, 2024

Study Completion Date

August 15, 2024

Conditions
Heathly Subjects
Interventions
DRUG

Flonoltinib Maleate Tablets

Day 1 will be used for drug administration, and Day 1\~Day 7 will be used for experimental data collection.

DRUG

Flonoltinib Maleate Tablets placebo

Day 1 will be used for drug administration, and Day 1\~Day 7 will be used for experimental data collection.

Trial Locations (1)

610000

Chengdu Xinhua Hospital, Chengdu

All Listed Sponsors
lead

Chengdu Zenitar Biomedical Technology Co., Ltd

INDUSTRY

NCT06387966 - A Phase I Clinical Study of Flonoltinib Maleate Tablets in Healthy Subjects | Biotech Hunter | Biotech Hunter